Wednesday, September 02, 2009 8:31:20 AM
"Dear ******************,
Thank you for your message to the Division of Drug Information at the Center for Drug Evaluation and Research (CDER), one of the five centers within the Food and Drug Administration (FDA).
We do appreciate that you have contacted us and the time and effort spent in your communication. We understand your concern and we are aware of the extent of public interest in Ampligen.
However, we cannot discuss or offer any information on Ampligen inasmuch as all such information is confidential according to 21 Code of Federal Regulations (CFR) 314.430, and belongs to the manufacturer/sponsor developing the drug, so we cannot provide it to the public.
For background information, the Advisory Committees (AC) do not review review drug applications. The ACs operate in a purely advisory capacity.
Best regards,
Drug Information BLS
Division of Drug Information
Center for Drug Evaluation and Research
Food and Drug Administration
For up-to-date drug information, follow the FDA's Division of Drug Information on Twitter at FDA_Drug_Info
This communication is consistent with 21CFR10.85(k) and constitutes an informal communication that represents our best judgment at this time but does not constitute an advisory opinion, does not necessarily represent the formal position of the FDA, and does not bind or otherwise obligate or commit the agency to the views expressed.
"
Better be LUCKY than GOOD
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM